An innovative project led by Dr. Guy Rouleau at The Neuro has received major funding from Brain Canada, one of four platforms that are advancing treatment discovery across a wide range of neurological disorders. In total the four platforms are being supported with a $8,926,500 investment.
To address the growing problem of overprescribing for seniors, a new Canadian guideline is calling for routine medication reviews.
In Canada, roughly two in three adults age 65 or older take five or more medications. While often necessary, complex drug regimens can increase the risk of side effects and affect quality of life.
Researchers at McGill University are leading two major new Brain Canada-supported platforms to accelerate discovery and improve outcomes for patients living with neurological disorders, as announced today.
Award from the Burroughs Wellcome Fund will open new avenues to preventing and treating pneumonia.
A new study has revealed a group of blood proteins, that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test could one day identify people at high risk of MS in time to act before damage occurs.
Researchers at McGill University have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.
The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.
At event honouring 116 winners of major awards, keynote speaker and SSHRC Gold Medal recipient Myriam Denov emphasized the importance of listening.
McGill celebrated more than 100 researchers at the 21st edition of Bravo, a gala event May 7 honouring the winners of major provincial, national and international research prizes and awards in 2025.
The 2026 cohort of Distinguished James McGill Professors, James McGill Professors and William Dawson Scholars embody ‘the very best of our academic community’.
Provost and Executive Vice-President (Academic) Angela Campbell has named 31 McGill professors as Distinguished James McGill Professors, James McGill Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.
From fundamental physics to child well-being, McGill researchers advance discovery across disciplines
McGill has been awarded $18.1 million in federal funding to support 16 Canada Research Chairs – six new and 10 renewed.
Federal fund will support transformative high risk, high reward research across engineering, science, and medicine at McGill.
Icing a sprained ankle or sore muscle, long used to reduce pain and swelling, may in the longer run delay recovery and prolong pain, new research suggests.
In a preclinical study published in Anesthesiology, McGill University researchers found that even though cryotherapy (icing) eased pain in the short term, recovery time was more than doubled in some cases.
Scientists’ discovery of a molecular “switch” that activates an energy‑burning pathway in mice has the potential to lead to new treatments for bone disease.
The study, published in Nature, sheds new light on brown fat. Unlike white fat, which stores energy, brown fat cells burn calories, producing heat as a byproduct. For years, it was believed this process relied on a single pathway. More recently, researchers discovered a parallel pathway, but how it became activated remained a mystery.
As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust the shift from the Pap test to human papillomavirus (HPV) based screening.
The national survey, published in Current Oncology, examined women’s preferences for cervical screening – including how they want to be screened and how they want information communicated – as Canada transitions from Pap tests to HPV testing.
Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system’s first line of defence. NK cells can detect and destroy cancer cells, but tumours often create a protective barrier that blocks them, allowing cancer to grow.
Researchers at McGill University’s Rosalind & Morris Goodman Cancer Institute, in collaboration with the Research Institute of the McGill University Health Centre, found that suppressing two specific proteins helps NK cells overcome this blockage, turning them into more potent cancer killers.
Projects focusing on MedTech and genomics cut across disciplines while mobilizing expertise at McGill and other Quebec institutions to meet the challenges of today and tomorrow
